Thiazolides promote G1 cell cycle arrest in colorectal cancer cells by targeting the mitochondrial respiratory chain
- 16 December 2019
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 39 (11) , 2345-2357
Abstract
Systemic toxicity and tumor cell resistance still limit the efficacy of chemotherapy in colorectal cancer. Therefore, alternative treatments are desperately needed. The thiazolide Nitazoxanide (NTZ) is an FDA-approved drug for the treatment of parasite-mediated infectious diarrhea with a favorable safety profile. Interestingly, NTZ and the thiazolide RM4819—its bromo-derivative lacking antibiotic activity—are also promising candidates for cancer treatment. Yet the exact anticancer mechanism(s) of these compounds still remains unclear. In this study, we systematically investigated RM4819 and NTZ in 2D and 3D colorectal cancer culture systems. Both compounds strongly inhibited proliferation of colon carcinoma cell lines by promoting G1 phase cell cycle arrest. Thiazolide-induced cell cycle arrest was independent of the p53/p21 axis, but was mediated by inhibition of protein translation via the mTOR/c-Myc/p27 pathway, likely caused by inhibition of mitochondrial respiration. While both thiazolides demonstrated mitochondrial uncoupling activity, only RM4819 inhibited the mitochondrial respiratory chain complex III. Interestingly, thiazolides also potently inhibited the growth of murine colonic tumoroids in a comparable manner with cisplatin, while in contrast to cisplatin thiazolides did not affect the growth of primary intestinal organoids. Thus, thiazolides appear to have a tumor-selective antiproliferative activity, which offers new perspectives in the treatment of colorectal cancer.Keywords
This publication has 58 references indexed in Scilit:
- Nitazoxanide Stimulates Autophagy and Inhibits mTORC1 Signaling and Intracellular Proliferation of Mycobacterium tuberculosisPLOS Pathogens, 2012
- Nitazoxanide Disrupts Membrane Potential and Intrabacterial pH Homeostasis of Mycobacterium tuberculosisACS Medicinal Chemistry Letters, 2011
- A Fluorescent Reporter of AMPK Activity and Cellular Energy StressCell Metabolism, 2011
- Alarm grows over management of antibiotic resistance fileCanadian Medical Association Journal, 2009
- Nitazoxanide Kills Replicating and Nonreplicating Mycobacterium tuberculosis and Evades ResistanceJournal of Medicinal Chemistry, 2009
- Thiazolides inhibit growth and induce glutathione‐S‐transferase Pi (GSTP1)‐dependent cell death in human colon cancer cellsInternational Journal of Cancer, 2008
- Nitazoxanide: A New Thiazolide Antiparasitic AgentClinical Infectious Diseases, 2005
- Nitazoxanide in Treatment of Helicobacterpylori : a Clinical and In VitroStudyAntimicrobial Agents and Chemotherapy, 2003
- Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from PeruTransactions of the Royal Society of Tropical Medicine and Hygiene, 2002
- Nitazoxanide, a Nitrothiazolide Antiparasitic Drug, Is an Anti-Helicobacter pylori Agent with Anti-Vacuolating Toxin ActivityChemotherapy, 1999